Literature DB >> 1820443

Total and regional bone mineral content in patients with non-insulin dependent diabetes mellitus.

Y Okuno1, Y Nishizawa, K Sekiya, S Hagiwara, T Miki, H Morii.   

Abstract

Total body bone mineral content and bone mineral content in various body sites were measured by dual-photon absorptiometry in 103 patients with non-insulin-dependent diabetes mellitus (NIDDM) and the findings were compared with those for 214 non-diabetic control subjects matched for age and body weight. Neither total body bone mineral content (TBBM) nor the bone mineral density of the third lumbar vertebra (L3 BMD) in the diabetic subjects differed from the values in control subjects of either sex, but the values were significantly decreased in patients diseased for at least five years when compared with control subjects. Regional bone mineral measurement showed prominent bone loss in the truncal site, but no reduction in bone mass was found in the head, pelvis, arms, or legs in either male or female patients. These results suggest that reduced TBBM and L3 BMD are associated with duration of the disease and that a site-specific bone defect is present in NIDDM.

Entities:  

Mesh:

Year:  1991        PMID: 1820443     DOI: 10.3177/jnsv.37.supplement_s43

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  6 in total

1.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

2.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.

Authors:  M Inaba; Y Nishizawa; A Shioi; H Morii
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.

Authors:  I I de Liefde; M van der Klift; C E D H de Laet; P L A van Daele; A Hofman; H A P Pols
Journal:  Osteoporos Int       Date:  2005-06-07       Impact factor: 4.507

5.  FRAX (Australia) scores in women with impaired fasting glucose and diabetes.

Authors:  Lelia L F de Abreu; Kara L Holloway-Kew; Muhammad A Sajjad; Mark A Kotowicz; Julie A Pasco
Journal:  Bone Rep       Date:  2019-08-13

6.  Short-term caloric restriction does not reduce bone mineral density in rats with early type 2 diabetes.

Authors:  Yun Kyung Jeon; Won Jin Kim; Myung Jun Shin; Hae-Young Chung; Sang Soo Kim; Bo Hyun Kim; Seong-Jang Kim; Yong Ki Kim; In Joo Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.